Study Suggests COVID-19 Vaccine May Increase Risk of Myocarditis, Guillain-Barr Syndrome, Other Side Effects – AboutLawsuits.com

Researchers looked for side effects occurring up to 42 days after vaccination with Pfizer and Moderna mRNA and AstraZeneca viral-vector vaccines. It is the largest COVID vaccine study conducted to date, and included data from 183 million doses of the Pfizer mRNA vaccine, 36 million doses of the Moderna mRNA vaccine, and 23 million doses of the AstraZeneca adenovirus-vector vaccine.

According to the findings, the risk of pericarditis was nearly seven times higher among those who took a third dose of AstraZenecas viral vector vaccine. It was 1.7 and 2.6 times higher among patients who took a first and fourth dose of Modernas mRNA vaccine, respectively.

The data indicates patients who received the first, second, and third doses of any mRNA vaccines faced a slightly increased risk of myocarditis, which is a heart condition marked by inflammation of the outer lining of the heart. The risk was six times higher after the second Moderna dose.

The COVID-19 vaccines were also linked to a potential risk of pericarditis, which involves swelling of the saclike tissue that surrounds the heart. Both myocarditis and pericarditis can lead to symptoms like a heart attack, including sharp chest pains.

Guillain-Barre syndrome is a condition that affects the nerves, which can cause weakness and tingling in the feet and legs that can spread to other parts of the body. Researchers found that the risk for Guillain-Barre syndrome from the COVID-19 vaccine was 2.5 times higher, and individuals who received the AstraZeneca vaccine were three times more likely to develop venous sinus thrombosis, which is a condition that causes blood clots in the major veins in the brain and can cause headaches, seizures, and weakened limbs.

The researchers also determined patients faced nearly four times the risk of developing acute disseminated encephalomyelitis, a type of inflammation and swelling of the brain, when they took the Moderna vaccine. They also faced twice the risk of the condition if they took the AstraZeneca vaccine.

Researchers said the data confirmed a small risk of developing the various conditions based on the type of vaccine that was administered. But the risk of contracting COVID-19 and facing serious infection, complications, or death is still much higher than the risk from the blood, brain, and heart conditions outlined in the study.

The risk of having a neurological side effect after COVID-19 infection is 617 times higher than the risk faced after receiving any COVID-19 vaccine. The same is true for developing myocarditis or another heart condition after contracting the COVID virus compared to the COVID vaccine, they determined.

So far, roughly 71% of the worlds population has received at least one dose of a COVID vaccine. More than 13.5 billion doses have been administered since the start of the pandemic.

Despite an uptick in COVID-19 infections this winter from the JN.1 variant, COVID cases, hospitalizations, and deaths are declining overall, researchers say, due to the widespread administration of COVID-19 vaccines.

Read the original post:

Study Suggests COVID-19 Vaccine May Increase Risk of Myocarditis, Guillain-Barr Syndrome, Other Side Effects - AboutLawsuits.com